Correction to: Impact of Oral Abrocitinib Monotherapy on Patient-Reported Symptoms and Quality of Life in Adolescents and Adults with Moderate-to-Severe Atopic Dermatitis: A Pooled Analysis of Patient-Reported Outcomes

Correction to: American Journal of Clinical Dermatology (2021) 22: 541–554 10.1007/s40257-021-00604-9

Page 550, Fig. 4:

The legend, which previously read:

Fig. 4. Impact of treatment on a Dermatology Life Quality Index (DLQI)^a and b Children’s Dermatology Life Quality Index (CDLQI)^b band descriptors. ^aFor patients ≥ 8 years of age. ^bFor patients < 18 years of age.

Should read:

Fig. 4. Impact of treatment on a Dermatology Life Quality Index (DLQI)^a and b Children’s Dermatology Life Quality Index (CDLQI)^b band descriptors. ^aFor patients ≥ 18 years of age. ^bFor patients < 18 years of age.